These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18664561)

  • 1. Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours.
    Gosens MJ; Dresen RC; Rutten HJ; Nieuwenhuijzen GA; van der Laak JA; Martijn H; Tan-Go I; Nagtegaal ID; van den Brule AJ; van Krieken JH
    Ann Oncol; 2008 Dec; 19(12):2026-32. PubMed ID: 18664561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y; Wexner SD; Berho M
    Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.
    Rödel F; Hoffmann J; Grabenbauer GG; Papadopoulos T; Weiss C; Günther K; Schick C; Sauer R; Rödel C
    Strahlenther Onkol; 2002 Aug; 178(8):426-35. PubMed ID: 12240548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer.
    Tannapfel A; Nüsslein S; Fietkau R; Katalinic A; Köckerling F; Wittekind C
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):585-91. PubMed ID: 9635706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression.
    Scott N; Hale A; Deakin M; Hand P; Adab FA; Hall C; Williams GT; Elder JB
    Eur J Surg Oncol; 1998 Jun; 24(3):169-73. PubMed ID: 9630854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic proteins as prognostic markers and indicators of radiochemosensitivity in stage II/III rectal cancers.
    Fucini C; Messerini L; Saieva C; Orzalesi L; Carroni V; Bartolini N
    Colorectal Dis; 2012 Feb; 14(2):e64-71. PubMed ID: 21848899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
    Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
    Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence and significance of preoperative intraarterial infusion chemotherapy combined with radiotherapy on survivin, p53 and Bax expression in low rectal carcinoma].
    Gan JL; Guo Y; Tang ZJ; Gao F; Tang WZ; Liu XJ
    Ai Zheng; 2006 Nov; 25(11):1423-7. PubMed ID: 17094914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
    Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
    In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proliferation and apoptosis before and after preoperative simultaneous radiochemotherapy of rectal carcinomas].
    Tannapfel A; Nüsslein S; Katalinic A; Köckerling F; Wittekind C; Fietkau R
    Strahlenther Onkol; 1998 Jun; 174(6):295-9. PubMed ID: 9645209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer.
    Rödel C; Grabenbauer GG; Papadopoulos T; Bigalke M; Günther K; Schick C; Peters A; Sauer R; Rödel F
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):294-303. PubMed ID: 11872273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
    Rau B; Sturm I; Lage H; Berger S; Schneider U; Hauptmann S; Wust P; Riess H; Schlag PM; Dörken B; Daniel PT
    J Clin Oncol; 2003 Sep; 21(18):3391-401. PubMed ID: 12885834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic markers predictive of response to induction chemoradiotherapy for locally advanced rectal cancers.
    Kudrimoti M; Lee EY; Kang Y; Ahmed M; Mohiuddin M
    J Ky Med Assoc; 2007 Jan; 105(1):18-22. PubMed ID: 17310874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis.
    Hecht M; Büttner-Herold M; Erlenbach-Wünsch K; Haderlein M; Croner R; Grützmann R; Hartmann A; Fietkau R; Distel LV
    Eur J Cancer; 2016 Sep; 65():52-60. PubMed ID: 27468145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.
    Sprenger T; Conradi LC; Beissbarth T; Ermert H; Homayounfar K; Middel P; Rüschoff J; Wolff HA; Schüler P; Ghadimi BM; Rödel C; Becker H; Rödel F; Liersch T
    Cancer; 2013 Jan; 119(1):26-35. PubMed ID: 22736392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma.
    Bandoh N; Hayashi T; Kishibe K; Takahara M; Imada M; Nonaka S; Harabuchi Y
    Cancer; 2002 Apr; 94(7):1968-80. PubMed ID: 11932899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).
    Brouquet A; Bachet JB; Huguet F; Karoui M; Artru P; Sabbagh C; Lefèvre JH; Vernerey D; Mariette C; Vicaut E; Benoist S;
    BMC Cancer; 2020 May; 20(1):485. PubMed ID: 32471382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of APAF-1 and COX-2 expression in pathologic complete response to neoadjuvant chemoradiotherapy for patients with locally advanced rectal adenocarcinoma.
    Peng H; You K; Zhang R; Xi S; Zhang T; Dong J; Cai M; Wang C; Zhang H; Zhou T; Gao Y; Wen B
    Oncotarget; 2016 Jun; 7(23):35233-40. PubMed ID: 27153549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax).
    de la Torre FJ; García A; Gil-Moreno A; Planaguma J; Reventos J; Ramón y Cajal S; Xercavins J
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):121-8. PubMed ID: 16876311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.